Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHSG-KF versus split-thickness skin graft for large full-thickness skin defects
NL-OMON56452Phase 2Recruiting
- Sponsor
- CUTISS
- Start
- May 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of denovoSkin, sponsored by CUTISS. Primary endpoint: POSAS observer total score. Started May 2019; status: recruiting.
02
Drugs
denovoSkin
Beyond the preview
Go deeper on NL-OMON56452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56452.